SD
IFF
BHC
BLCO
IEP

Brett Icahn

Known title: DirectorCIK: 0001387184

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

SandRidge Energy Reviewed in Yahoo Energy Stock Comparison. The Yahoo article compares SandRidge Energy to PrimeEnergy, examining factors like valuation and dividend yield. SandRidge trades with a trailing P/E of 6.1 and a 2.76% dividend, and analysts set a target of $14.00. The piece highlights how SandRidge’s metrics stack against its peer, providing context for investors.

this person other insiders at SD

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

IFF to Report Q3 2026 Results on November 3. International Flavors & Fragrances is scheduled to release its third-quarter 2026 earnings on November 3, 2026. This upcoming report is the primary driver of recent attention for the stock. The company's shares have been trading near the upper end of their 52-week range, with an RSI of 75.3 suggesting strong recent momentum ahead of the announcement.

this person other insiders at IFF

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

BHC appoints interim CEO and looks to raise FY26 EBITDA guidance. Bausch Health announced that its chairman, Thomas J. Appio, will serve as interim chief executive effective immediately. The company and its parent also said they expect to raise the adjusted EBITDA guidance for fiscal year 2026, not including the recently acquired IPR&D business. A separate notice confirms that the firm will release its third‑quarter 2026 results on October 28. Analysts at Zacks included Bausch Health in a recent coverage roundup, highlighting the stock among other health‑care names.

this person other insiders at BHC

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

BLCO Advances Oral Dry AMD Treatment After FDA Meeting. Bausch + Lomb reported progress on a new oral drug for dry age‑related macular degeneration after a constructive meeting with the FDA. The company said the discussion helped clarify the regulatory pathway and the drug’s development plan. It also announced that its third‑quarter 2026 earnings will be released on Oct. 28, giving investors a future update on performance.

this person other insiders at BLCO

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

IEP Featured in Whale Alerts and Dividend Risk Lists. Icahn Enterprises L.P. appeared in recent market reports highlighting unusual trading volume and potential risks associated with its high dividend yield. These mentions draw attention to the stock's current valuation and payout structure. The news serves as a reminder for investors to review the underlying financial health behind the reported yield.

this person other insiders at IEP

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Newell Brands (NWL) Faces Valuation Questions Amid Sector Slowdown. Recent coverage highlights whether Newell Brands is undervalued while its peer Kimberly-Clark navigates slower growth in consumer categories. The stock is currently trading near a key support level, with analysts maintaining a wide range of price targets. This context suggests investors are weighing fundamental value against broader sector headwinds.

this person other insiders at NWL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Dana Gets EU Approval For Eaton Mobility Deal. Dana Incorporated has received European Commission approval to acquire Eaton's mobility operations. This regulatory green light is a key step in finalizing the transaction, which aims to expand Dana's presence in the European market. The approval removes a major uncertainty that had been weighing on the deal's timeline.

this person other insiders at DAN

Transaction History

SD▲ Buy$150K
IFF▲ Buy$0
IFF▲ Buy$838K
IFF▲ Buy$1.3M
SD▲ Buy$129K
BHC▲ Buy$0
BLCO▲ Buy$0
BHC▲ Buy$0
BHC▲ Buy$33K
BHC▲ Buy$33K
IEP▼ Sell$457K
BHC▲ Buy$33K
BLCO▲ Buy$0
BHC▲ Buy$33K
BHC▲ Buy$0
BHC▲ Buy$33K
BHC▲ Buy$33K
IEP▼ Sell$588K
BHC▲ Buy$33K
BHC▲ Buy$33K
BHC▲ Buy$0
BLCO▲ Buy$0
BHC▲ Buy$30K
NWL▼ Sell$5.6M
NWL▼ Sell$1.4M
DAN▲ Buy$0
DAN▲ Buy$0
NWL▼ Sell$1.7M
NWL▼ Sell$404K
BHC▲ Buy$29K
IEP▼ Sell$892K
BHC▲ Buy$31K
NWL▼ Sell$1.2M
NWL▼ Sell$171K
NWL▼ Sell$2.6M
NWL▼ Sell$2.6M
BHC▲ Buy$31K
BLCO▲ Buy$0
BHC▲ Buy$0
NWL▲ Buy$0
BHC▲ Buy$31K
BHC▲ Buy$31K
IEP▼ Sell$785K
BHC▲ Buy$31K
IEP▲ Buy$0
IEP▲ Buy$10.0M

We use analytics to understand how market-wall is used. No personal data is sold.